BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Leukocyte
,
Biofuel
,
Quercetin
,
rs2300478
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
XIAP
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Frontal cortex
Spleen
Prefrontal cortex
Globus pallidum external
Thyroid gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Other lymphoma
Pyloric ulcer
Injury of liver
Disorder of pregnancy
Bacterial pneumonia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Carotenoids
dyclonine
Hydrogen
Butirosin Sulfate
isocorydine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mcs5
SAR1A
TRIB2
MGMT
SAR1B
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflam…
Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
Identification of Germline Non-coding Deletions in XIAP Gene Causing XIAP Deficiency Reveals a Key P…
Interleukin-1-mediated hyperinflammation in XIAP deficiency is associated with defective autophagy.
X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three iden…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
Study of XIAP Antisense for Advanced Cancers
XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carci…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ